1 / 22

ADNI PiB Amyloid Imaging Chet Mathis University of Pittsburgh

ADNI PiB Amyloid Imaging Chet Mathis University of Pittsburgh. Enrollment in ADNI PiB Studies to June 2010 ( All Data Are Available On The LONI Website). Baseline – 103 Subjects at 14 PET Sites. NL: 19, 78±5 y/o, MMSE 29±1 MCI: 65, 75±8 y/o, MMSE 27±2 AD: 19, 73±9 y/o, MMSE 22±3.

yuma
Download Presentation

ADNI PiB Amyloid Imaging Chet Mathis University of Pittsburgh

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. ADNI PiB Amyloid ImagingChet MathisUniversity of Pittsburgh

  2. Enrollment in ADNI PiB Studies to June 2010(All Data Are Available On The LONI Website) Baseline – 103 Subjects at 14 PET Sites • NL: 19, 78±5 y/o, MMSE 29±1 • MCI: 65, 75±8 y/o, MMSE 27±2 • AD: 19, 73±9 y/o, MMSE 22±3 1 Yr Longitudinal Studies – 80 Subjects • NL: 17/19 (89%) • MCI: 50/65 (77%) • AD: 13/19 (68%) 2 Yr Longitudinal Studies – 39 Subjects • NL: 11 • MCI: 26 • AD: 2 3 Yr Longitudinal Studies – 2 Subjects • NL: 2 • MCI: 0 • AD: 0 • PiB Baseline Entry Times • 20 subjects at ADNI true baseline • 69 subjects at ADNI 12 months • 14 subjects at ADNI 24 months Total 224 PiB Scans

  3. Baseline PiB Studies: 103 Subjects (19 NL, 65 MCI, 19 AD)

  4. 9 47 17 10 2 18 Baseline ADNI PiB Subjects 3.5 NL MCI 3.0 AD 2.5 SUVR 50-70 PiB(+) 2.0 Cut-off 1.5 1.0 NeoC4 Ave ACG FC PRC PAR Cut-Off: Aizenstein et al., Arch Neurol 2008; 65:1509-17

  5. PiB(-) PiB(+) 18 9 47 n = 10 17 2 PiB NeoC4 SUVR Baseline Values by Subject Group 2.0 SUVR 50-70 1.5 1.0 NL MCI AD

  6. 1 Year Longitudinal PiB Follow-Up Studies: 80 Subjects (17 NL, 50 MCI, 13 AD)

  7. 1 Year Changes in PiB NeoC4 SUVR Values by Subject Group Baseline 1 year Baseline 1 year 8 1 12 N = 9 16 34

  8. 2 Year Changes in PiB NeoC4 SUVR Values by Subject Group Baseline 2 year Baseline 2 year 4 N = 7 11 2 15

  9. Logan DVR 2.0 1.0 Longitudinal PiB Studies Cognitively Normal Elderly Subject Baseline 1 Yr 2 Yr

  10. 30% +1.645 (one-tailed) p=0.05 25% 20% >0.215 -SUVR Frequency 15% 10% 5% 0% 0.1 0.2 0.3 -0.1 -0.3 -0.2 0.15 0.25 -0.25 -0.15 +/-0.05 Delta SUVR PiB NeoC4 Reliable Change Index (RCI)Defined Using Test-Retest Scans

  11. ADNI PiB Longitudinal RCI Data 1 Yr Significant PiB NeoC4 RCI Changes All PiB(-) 2/26 = 8% All PiB(+) 11/54 = 20%

  12. ADNI PiB Longitudinal RCI Data 2 Yr Significant PiB NeoC4 RCI Changes All PiB(-) 0/17 = 0% All PiB(+) 4/22 = 18%

  13. Mild Cognitive Impairment: Predictive Value of PiB Scanning

  14. MCI’s Cover the Range of Amyloid Load Lopresti et al., J Nuclear Medicine 2005

  15. Does PiB-Positivity Predict Clinical Conversion of MCI to AD? Three Published Studies To Date: Forsberg et al., Neurobiol Aging 2008 Wolk et al., Annals of Neurology2009 Okello et al., Neurology 2009 Over 1-2 Years of Follow-Up PiB(+) MCI  AD Converters: 26/44 (59%) PiB(-) MCI  ADConverters: 1/21 (5%)

  16. Does PiB-Positivity Predict Clinical Conversion of MCI to AD? ADNI PiB MCI Conversion Data Over 1-2 Years of Follow-Up PiB(+) MCI  AD Converters: 21/47 (45%) PiB(-) MCI  ADConverters: 3/18 (16%)

  17. PiB(-) 3.0 1.21 PiB NeoC4 SUVR: 1.22 1.43 1.0 PiB NeoC4 SUVR: 2.11 2.26 2.54 ADNI PiB Converters from MCI to AD “not clearly abnormal, although borderline abnormalities are limited to frontal regions” “severely abnormal FDG scan with an FTD-like pattern; highly confident of FTD” “abnormal FDG scan with an FTD-like pattern” PiB(+)

  18. Use of Pons as Reference Region

  19. Baseline ADNI PiB Subjects (PONS) 9 45 17 10 2 20 2.4 NL MCI AD 1.6 PiB(+) SUVR 50-70 Cut-off 0.80 0.0 NeoC4 Ave ACG FC PRC PAR

  20. 9 47 17 10 2 18 Baseline ADNI PiB Subjects 3.5 NL MCI 3.0 AD 2.5 SUVR 50-70 PiB(+) 2.0 Cut-off 1.5 1.0 NeoC4 Ave ACG FC PRC PAR Cut-Off: Aizenstein et al., Arch Neurol 2008; 65:1509-17

  21. ADNI PiB Summary • Results from baseline ADNI PiB scans are generally consistent • with other groups and the literature • Year 1 and 2 longitudinal PiB scans show small or no group • increases, but ~20% of individual PiB(+) subjects show significant • increases over 1-2 year • ADNI PiB MCI to AD conversion data show ~3X as many PiB(+) • conversions than PiB(-) conversions. More ADNI PiB(-) converted • compared to literature data, but the n is low for ADNI and 2 of 3 • PiB(-) subjects had an FDG pattern consistent with FTD not AD • Use of Pons as the reference region made little difference in data • analysis results and interpretation • ADNI PiB data contain more noise than data collected at one site, • but provide a useful, open database for investigators

  22. Acknowledgements • ADNI PiB Funding • Alzheimer’s Association • GEHC • Collaborators • Bill Jagust, UC Berkeley • Bob Koeppe, U Michigan • Norm Foster, U Utah • Bill Klunk, U Pittsburgh • Julie Price, U Pittsburgh

More Related